GridAI Technologies (GRDX) Non Operating Income (2020 - 2025)
GridAI Technologies' (GRDX) quarterly Non Operating Income came in at $533459.0 in Q4 2025, up 266629.5% YoY from N/an in Q4 2024, and up 1579.0% on a QoQ basis from -$36069.0 in Q3 2025.
GridAI Technologies (GRDX) Non Operating Income (2020 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 6 years of Non Operating Income data on file, last reported at $533459.0 in Q4 2025.
- Quarterly Non Operating Income rose 266629.5% year-over-year to $533459.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $334604.0 (up 8241.22% YoY) and the FY2025 annual result came in at $443422.0, up 50576.8% from the prior year.
- Non Operating Income climbed to $533459.0 in Q4 2025, from -$36069.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $533459.0 in Q4 2025 to a low of -$1.7 million in Q4 2022.
- A 5-year average of -$56309.9 and a median of -$3203.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income slumped 30890.16% — and 2025, when it jumped 266629.5%.
- Tracing GRDX's Non Operating Income over 5 years: stood at -$5506.0 in 2021, then tumbled by 30890.16% to -$1.7 million in 2022, then jumped by 99.57% to -$7319.0 in 2023, then surged by 102.73% to $200.0 in 2024, then jumped by 266629.5% to $533459.0 in 2025.
- The last three Non Operating Income figures came in at $533459.0 (Q4 2025), -$36069.0 (Q3 2025), and -$36067.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | 642,277.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 533,459.00 |
| Sep 30, 2025 | -36,069.00 |
| Jun 30, 2025 | -36,067.00 |
| Mar 31, 2025 | -126,719.00 |
| Dec 31, 2024 | 200.00 |
| Sep 30, 2024 | 229.00 |
| Jun 30, 2024 | -4,114.00 |
| Mar 31, 2024 | -425.00 |
| Dec 31, 2023 | -7,319.00 |
| Sep 30, 2023 | -1,021.00 |
| Jun 30, 2023 | -7,588.00 |
| Mar 31, 2023 | -8,228.00 |
| Dec 31, 2022 | -1.71 Mn |
| Sep 30, 2022 | 1,801.00 |
| Jun 30, 2022 | -2,292.00 |
| Mar 31, 2022 | -244,767.00 |
| Dec 31, 2021 | -5,506.00 |
| Sep 30, 2021 | -1,310.00 |
| Jun 30, 2021 | -2,056.00 |
| Mar 31, 2021 | 527,912.00 |